NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Tether says new court order to produce USDT reserve backing is a ‘routine discovery matter’.